1. Home
  2. SGMT vs GRWG Comparison

SGMT vs GRWG Comparison

Compare SGMT & GRWG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SGMT
  • GRWG
  • Stock Information
  • Founded
  • SGMT 2006
  • GRWG 2008
  • Country
  • SGMT United States
  • GRWG United States
  • Employees
  • SGMT N/A
  • GRWG N/A
  • Industry
  • SGMT
  • GRWG RETAIL: Building Materials
  • Sector
  • SGMT
  • GRWG Consumer Discretionary
  • Exchange
  • SGMT Nasdaq
  • GRWG Nasdaq
  • Market Cap
  • SGMT 93.7M
  • GRWG 102.4M
  • IPO Year
  • SGMT 2023
  • GRWG N/A
  • Fundamental
  • Price
  • SGMT $5.18
  • GRWG $1.78
  • Analyst Decision
  • SGMT Strong Buy
  • GRWG Hold
  • Analyst Count
  • SGMT 5
  • GRWG 5
  • Target Price
  • SGMT $21.60
  • GRWG $2.75
  • AVG Volume (30 Days)
  • SGMT 772.8K
  • GRWG 595.1K
  • Earning Date
  • SGMT 11-13-2024
  • GRWG 11-12-2024
  • Dividend Yield
  • SGMT N/A
  • GRWG N/A
  • EPS Growth
  • SGMT N/A
  • GRWG N/A
  • EPS
  • SGMT N/A
  • GRWG N/A
  • Revenue
  • SGMT $2,000,000.00
  • GRWG $200,882,000.00
  • Revenue This Year
  • SGMT N/A
  • GRWG N/A
  • Revenue Next Year
  • SGMT N/A
  • GRWG N/A
  • P/E Ratio
  • SGMT N/A
  • GRWG N/A
  • Revenue Growth
  • SGMT N/A
  • GRWG N/A
  • 52 Week Low
  • SGMT $2.25
  • GRWG $1.70
  • 52 Week High
  • SGMT $20.71
  • GRWG $3.38
  • Technical
  • Relative Strength Index (RSI)
  • SGMT 47.83
  • GRWG 38.56
  • Support Level
  • SGMT $5.61
  • GRWG $1.70
  • Resistance Level
  • SGMT $6.40
  • GRWG $2.00
  • Average True Range (ATR)
  • SGMT 0.52
  • GRWG 0.13
  • MACD
  • SGMT -0.10
  • GRWG -0.03
  • Stochastic Oscillator
  • SGMT 17.57
  • GRWG 15.32

About SGMT Sagimet Biosciences Inc. Series A

Sagimet Biosciences Inc is a clinical-stage biopharmaceutical company focused on developing a portfolio of in-house discovered, selective fatty acid synthase (FASN) inhibitors for the treatment of diseases that result from dysfunctional lipid metabolism pathways. The company's lead drug candidate, denifanstat, is an oral, once-daily pill and selective FASN inhibitor in development for the treatment of nonalcoholic steatohepatitis (NASH).

About GRWG GrowGeneration Corp.

GrowGeneration Corp owns and operates specialty retail hydroponic and organic gardening stores. The firm is a marketer and distributor of nutrients, growing media, advanced indoor and greenhouse lighting, ventilation systems and accessories for hydroponic gardening. The Company has two reportable segments, including Cultivation and Gardening segment, composed of the Company's hydroponic and organic gardening business; and the Storage Solutions segment, composed of the Company's benching, racking, and storage solutions business.

Share on Social Networks: